Landscape Capital Management L.L.C. acquired a new stake in shares of Molina Healthcare, Inc (NYSE:MOH – Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 5,032 shares of the company’s stock, valued at approximately $1,151,000.
Other institutional investors and hedge funds have also modified their holdings of the company. 7G Capital Management LLC acquired a new position in Molina Healthcare in the fourth quarter valued at approximately $1,735,000. BNP Paribas Financial Markets grew its stake in shares of Molina Healthcare by 63.0% during the 4th quarter. BNP Paribas Financial Markets now owns 439,371 shares of the company’s stock worth $76,248,000 after purchasing an additional 169,739 shares during the period. Assenagon Asset Management S.A. grew its stake in shares of Molina Healthcare by 394.1% during the 2nd quarter. Assenagon Asset Management S.A. now owns 156,632 shares of the company’s stock worth $35,822,000 after purchasing an additional 124,929 shares during the period. M&T Bank Corp increased its holdings in shares of Molina Healthcare by 451.1% during the 4th quarter. M&T Bank Corp now owns 42,455 shares of the company’s stock valued at $7,368,000 after purchasing an additional 34,751 shares in the last quarter. Finally, Aurora Investment Managers LLC. purchased a new position in shares of Molina Healthcare during the 1st quarter valued at approximately $2,349,000. Institutional investors and hedge funds own 98.50% of the company’s stock.
Analyst Ratings Changes
Several research firms recently issued reports on MOH. Morgan Stanley boosted their target price on shares of Molina Healthcare from $146.00 to $167.00 and gave the company an “equal weight” rating in a research note on Thursday, June 4th. JPMorgan Chase & Co. raised their price target on shares of Molina Healthcare from $169.00 to $191.00 and gave the company a “neutral” rating in a research report on Monday, June 8th. Barclays cut their price objective on shares of Molina Healthcare from $184.00 to $180.00 and set an “underweight” rating for the company in a report on Friday, July 24th. Mizuho set a $215.00 price objective on shares of Molina Healthcare in a research report on Monday, June 8th. Finally, Jefferies Financial Group set a $230.00 target price on shares of Molina Healthcare in a research note on Tuesday, July 14th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, eleven have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $202.44.
Molina Healthcare Trading Up 0.2%
Shares of MOH stock opened at $200.63 on Monday. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.68 and a quick ratio of 1.68. The company has a market cap of $10.47 billion, a price-to-earnings ratio of -1,114.55, a PEG ratio of 28.70 and a beta of 0.75. The stock has a 50 day simple moving average of $211.25 and a 200-day simple moving average of $178.56. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $244.89.
Molina Healthcare (NYSE:MOH – Get Free Report) last announced its earnings results on Wednesday, July 22nd. The company reported $1.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.12. The firm had revenue of $10.87 billion for the quarter, compared to analyst estimates of $10.83 billion. Molina Healthcare had a positive return on equity of 3.73% and a negative net margin of 0.02%.The business’s revenue was down 4.8% on a year-over-year basis. During the same quarter last year, the firm posted $5.48 EPS. On average, equities research analysts expect that Molina Healthcare, Inc will post 5.29 EPS for the current fiscal year.
Molina Healthcare Company Profile
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
See Also
- Five stocks we like better than Molina Healthcare
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
